Company intelligence / Profile preview

InnoUp Farma

Pamplona/Noain, Navarre/Navarra, Spaininnoupfarma.com ↗
Ownership
Private
Development stage
Other
01

Overview

InnoUp Farma has developed a patented nanoparticle-based oral drug delivery platform. Its two lead clinical-stage assets are an oral immunotherapy for peanut allergy (INP20) and an oral formulation of paclitaxel chemotherapy for metastatic breast cancer (INP12), both reportedly in Phase 2 trials. The technology aims to improve the safety, efficacy, and patient convenience of drugs that are otherwise difficult to deliver orally due to low bioavailability or toxicity concerns. The company also explores the use of its nanoparticle system as an adjuvant in vaccines and immunotherapies.

Therapeutic areas
OncologyImmunologyPulmonology
Modalities
NanoparticleSmall moleculeAllergen extractProphylactic vaccine
Industry
Biotech
02

Drug pipeline

3 assets

INP20

2

2 more assets in the full pipeline.

Request access →
03

Partnerships

No specific major pharma/biotech partnerships disclosed; company states it seeks collaborations with companies/institutions.

Beyond the preview

Go deeper on InnoUp Farma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on InnoUp Farma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call